Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Mar 20;10(3):383.
doi: 10.3390/nu10030383.

Effects of Different Dietary and Lifestyle Modification Therapies on Metabolic Syndrome in Prediabetic Arab Patients: A 12-Month Longitudinal Study

Hanan A Alfawaz  1   2 , Kaiser Wani  3   4 , Abdullah M Alnaami  5   6 , Yousef Al-Saleh  7 , Naji J Aljohani  8 , Omar S Al-Attas  9   10 , Majed S Alokail  11   12 , Sudhesh Kumar  13 , Nasser M Al-Daghri  14   15
Affiliations
Randomized Controlled Trial

Effects of Different Dietary and Lifestyle Modification Therapies on Metabolic Syndrome in Prediabetic Arab Patients: A 12-Month Longitudinal Study

Hanan A Alfawaz et al. Nutrients. .

Abstract

This three-arm, randomized, controlled study aimed to determine the differences in the effects of general advice (GA) on lifestyle change, intensive lifestyle modification programme (ILMP) and GA + metformin (GA + Met) in reducing the prevalence of full metabolic syndrome (MetS) in subjects with prediabetes; 294 Saudis with prediabetes (fasting glucose 5.6-6.9 mmol/L) were initially randomized, 263 completed 6 months and 237 completed 12 months. They were allocated into three groups: GA group which received a standard lifestyle change education; ILMP which followed a rigorous lifestyle modification support on diet and physical activity; and a GA + Met group. Anthropometric and biochemical estimations were measured. Full MetS (primary endpoint) and its components (secondary endpoint) were screened at baseline, 6 and 12 months. Full MetS in the ILMP group decreased by 26% (p < 0.001); in GA + Met group by 22.4% (p = 0.01) and in GA group by 8.2% (p = 0.28). The number of MetS components decreased significantly in the ILMP and GA + Met groups (mean change 0.81, p < 0.001 and 0.35, p = 0.05, respectively). Between-group comparison revealed a clinically significant decrease in MetS components in favor of the ILMP group (-0.58 (-0.88-0.28), p < 0.001). This study highlights the clinical potency of ILMP versus other diabetes prevention options in reducing MetS in Saudi adults with elevated fasting glucose.

Keywords: impaired glucose regulation; lifestyle modifications; metabolic syndrome; metformin; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow chart detailing the participation of subjects and their allocation to treatment groups.
Figure 2
Figure 2
Odds ratio (OR) of MetS and its components for three treatment groups. The model is adjusted for age, sex, BMI and baseline covariates: waist, systolic and diastolic BP, fasting glucose, HbA1c, and vitamin D.
Figure 3
Figure 3
Intervention effects in total number of MetS components (A) and MetS risk-score (B) for three treatment strategies calculated at baseline and follow-up. Data is adjusted for age, sex and BMI, systolic and diastolic BP, waist, fasting glucose, HbA1c, and vitamin D (all baseline values). The overall change in ILMP and GA + Met groups versus GA group reported as Mean Change (95% confidence interval). Within group intervention effect is shown as * for p < 0.05 or ** for p < 0.01.
See this image and copyright information in PMC

References

    1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81–S90. - PubMed
    1. Prediabetes and the Potential to Prevent Diabetes. [(accessed on 15 March 2018)];Lancet. 2012 379 Available online: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960.... - PubMed
    1. Bray G.A., Ehrmann D.A., Goldberg R.B., Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403. - PMC - PubMed
    1. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., Hu Z.X., Xiao J.Z., Cao H.B., Liu P.A. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537–544. doi: 10.2337/diacare.20.4.537. - DOI - PubMed
    1. Ramachandran A., Snehalatha C., Mary S., Mukesh B., Bhaskar A., Vijay V. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) Diabetologia. 2006;49:289–297. doi: 10.1007/s00125-005-0097-z. - DOI - PubMed

Publication types

MeSH terms